Skip to content

Vitae Pharmaceuticals, Inc

Delisted

CIK 1157602fmd_0J6JGXKXBJHXN9EEKA7H5JWHYHManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2012 to Jun 30, 2016, 15 periods

Latest annual · FY2015

Millions
Total revenues
1
Operating income
(44)
Net income
(44)
Free cash flow
(38)

Latest quarter · Q2 FY2016

Millions
Total revenues
0
Operating income
(11)
Net income
(10)
Free cash flow
(9)
Open Financials

Key stats

Open Analysis

Compound annual growth

Revenue, 3 yearsFY2012 to FY2015
-70.4%

Vitae Pharmaceuticals, Inc financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2015FY2014ChangeSource
Revenue$579,674$8.7 million-93.3%10-K 2016-03-04 · proof
Operating income-$44.3 million-$18.5 million10-K 2016-03-04 · proof
Net income-$44 million-$19.1 million10-K 2016-03-04 · proof
Cash from operating activities-$38 million-$17.8 million10-K 2016-03-04 · proof
Free cash flow-$38.3 million-$18.1 million10-K 2016-03-04 · proof
Total assets$61.8 million$67.7 million-8.6%10-K 2016-03-04 · proof
Total liabilities$7.4 million$8.9 million-17.5%10-K 2016-03-04 · proof
Cash and cash equivalents$11.8 million$29.5 million-60.1%10-K 2016-03-04 · proof
What was Vitae Pharmaceuticals, Inc's revenue in fiscal 2015?
Vitae Pharmaceuticals, Inc reported revenue of $579,674 for fiscal 2015 (the year ended Dec 31, 2015), against $8.7 million the year before (-93.3%). Source: the 10-K filed with the SEC on Mar 4, 2016. SEC
What was Vitae Pharmaceuticals, Inc's operating income in fiscal 2015?
Vitae Pharmaceuticals, Inc reported operating income of -$44.3 million for fiscal 2015 (the year ended Dec 31, 2015), against -$18.5 million the year before. Source: the 10-K filed with the SEC on Mar 4, 2016. SEC
What was Vitae Pharmaceuticals, Inc's net income in fiscal 2015?
Vitae Pharmaceuticals, Inc reported net income of -$44 million for fiscal 2015 (the year ended Dec 31, 2015), against -$19.1 million the year before. Source: the 10-K filed with the SEC on Mar 4, 2016. SEC
What was Vitae Pharmaceuticals, Inc's cash from operating activities in fiscal 2015?
Vitae Pharmaceuticals, Inc reported cash from operating activities of -$38 million for fiscal 2015 (the year ended Dec 31, 2015), against -$17.8 million the year before. Source: the 10-K filed with the SEC on Mar 4, 2016. SEC
What was Vitae Pharmaceuticals, Inc's free cash flow in fiscal 2015?
Vitae Pharmaceuticals, Inc reported free cash flow of -$38.3 million for fiscal 2015 (the year ended Dec 31, 2015), against -$18.1 million the year before. Source: the 10-K filed with the SEC on Mar 4, 2016. SEC
What are Vitae Pharmaceuticals, Inc's total assets?
As of Dec 31, 2015, Vitae Pharmaceuticals, Inc reported total assets of $61.8 million, against $67.7 million a year earlier (-8.6%). Source: the 10-K filed with the SEC on Mar 4, 2016. SEC
What are Vitae Pharmaceuticals, Inc's total liabilities?
As of Dec 31, 2015, Vitae Pharmaceuticals, Inc reported total liabilities of $7.4 million, against $8.9 million a year earlier (-17.5%). Source: the 10-K filed with the SEC on Mar 4, 2016. SEC
What are Vitae Pharmaceuticals, Inc's cash and cash equivalents?
As of Dec 31, 2015, Vitae Pharmaceuticals, Inc reported cash and cash equivalents of $11.8 million, against $29.5 million a year earlier (-60.1%). Source: the 10-K filed with the SEC on Mar 4, 2016. SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1157602&period_type=annual&limit=5"

Information only, not investment advice.